Cardiovascular-Kidney-Metabolic Livestream
- Nov. 12 – 13, 2026 (Thu–Fri)
- Online
- 14.25 Credits
- Member$815
- Non-Member$1025
- New Physician$765
- Student$645
- Resident$645
- Other$815
Purchases may be subject to applicable sales tax.
EARLY BIRD PRICING ACTIVE: Prices go up on November 1!
Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
You will be encouraged to be a part of the conversation as we discuss overlapping co- and multi-morbidity cases related to CKM syndrome. Shift and advance your therapeutic decision-making from managing individual diseases to managing them as a syndrome.
Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
You will be encouraged to be a part of the conversation as we discuss overlapping co- and multi-morbidity cases related to CKM syndrome. Shift and advance your therapeutic decision-making from managing individual diseases to managing them as a syndrome.
Course details
Apply the AHA Cardiovascular-Kidney-Metabolic (CKM) framework and CKM staging to complex patient cases to recognize interrelated cardiometabolic, renal, and cardiovascular risk factors in primary care.
Use evidence-based screening, risk stratification, treatment intensification, referral, and follow-up strategies for patients with overlapping CKM conditions.
Integrate GLP-1 receptor agonists, SGLT2 inhibitors, lifestyle interventions, and other guideline-directed therapies into individualized care plans for patients with obesity, diabetes, chronic kidney disease, cardiovascular disease or heart failure.
Differentiate heart failure phenotypes and chronic kidney disease stages to inform treatment, referral and care coordination decisions in real-world CKM cases.
Develop practical, patient-centered management strategies that address multimorbidity, medication burden, access considerations and team-based care needs for patients with complex CKM risk and disease.
Through participatory PBLs you’ll turn complex, real world cases into advanced knowledge for stronger clinical decision-making. Here’s what you can expect as we dive into each stage of CKM:
Schedule (all times CST)
8:00 – 8:30 a.m.
Welcome and Introduction of CKM – Justin Bailey, MD
Stages 0–1: Focus on Prevention and Reducing the Development of Problematic Adiposity
8:30 – 9:15 a.m.
Putting CKM Staging into Practice: Identifying Risk Earlier in Complex Primary Care Patients
9:15 – 10:15 a.m.
Lifestyle Intervention in CKM: Practical Strategies That Reduce Risk and Support Long-Term Health
10:15 – 10:30 a.m.
Break
10:30 – 11:30 a.m.
Combating Misinformation and Social Media in Preventative CKM Care
11:30 a.m. – 12:30 p.m.
Lunch
Stage 2: Focus on Reducing Metabolic Risk and CKD
12:30 – 12:45 p.m.
Setting the Stage: Why CKM Stage 2 Matters in Primary Care – Justin Bailey, MD
12:45 – 1:45 p.m.
Lipid Management in CKM: Applying Guideline Updates to Reduce Cardiovascular Risk
1:45 – 2:30 p.m.
Diabetes Management in CKM: Applying New Evidence to Reduce Kidney and Cardiovascular Risk
2:30 – 2:45 p.m.
Break
2:45 – 3:30 p.m.
Blood Pressure Targets in CKM: Reconciling Guidelines for Real-World Primary Care
3:30 – 4:30 p.m.
Anemia in CKM: Recognizing Risk, Evaluating Causes, and Coordinating Care
4:30 p.m.
Recess
Stages 3 and 4 – Treatment of Subclinical and Clinical CVD
8:30 – 8:45 a.m.
Advancing CKM Care: Recognizing Stages 3–4 and Coordinating Treatment for Complex Disease – Justin Bailey, MD
8:45 – 9:30 a.m.
Coronary Disease in CKM: Preventing Events and Managing Angina, MI, and Residual Risk
9:30 – 10:15 a.m.
Cerebrovascular Disease in CKM: Reducing Stroke Risk Through Integrated Primary Care
10:15 – 10:30 a.m.
Break
10:30 – 11:15 a.m.
Heart Failure in CKM: Phenotyping, Treatment Intensification, and Team-Based Follow-Up
11:15 a.m. – 12:00 p.m.
Arrhythmias in CKM: Managing Atrial Fibrillation and Rhythm Risk in Complex Patients
12:00 – 1:00 p.m.
Lunch
1:00 – 1:45 p.m.
Social Drivers of CKM Health: Identifying Barriers and Building Practical Care Plans
1:45 – 2:00 p.m.
Deprescribing in CKM: Balancing Guideline-Directed Care, Frailty, and Patient Goals
2:00 – 2:45 p.m.
Patient Motivation in Primary Prevention
2:45 – 3:00 p.m.
Break
Case Studies/Problem Based Learning covering all stages
3:00 – 3:30 p.m.
Case Studies/Problem-Based Learning – Early CKM Risk in Practice: Case-Based Prevention for Stages 0–1
3:30 – 4:00 p.m.
Case Studies/Problem-Based Learning – CKM Stage 2 Cases: Reducing Metabolic Risk and Slowing Progression
4:00 – 4:30 p.m.
Case Studies/Problem-Based Learning –Advanced CKM Cases: Managing Stages 3–4, Multimorbidity, and Referral Decisions
4:30 p.m.
Adjourn
Credit Statement
The AAFP has reviewed Cardiovascular-Kidney-Metabolic Livestream and deemed it acceptable for up to 14.25 Live AAFP Prescribed credit(s). Term of approval is from 11/12/2026 to 11/13/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Family Physicians designates this Live activity for a maximum of 14.25 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Following this CME activity, participants will have the opportunity to earn an additional two Prescribed credits for participation in each Translation to Practice® exercise. Information on Translation to Practice® will be shared within the activity.